Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Liquid Biopsies and Cancer Immunotherapy. Cancer J 2018 Mar/Apr;24(2):78-83

Date

03/31/2018

Pubmed ID

29601334

DOI

10.1097/PPO.0000000000000307

Scopus ID

2-s2.0-85044928489   8 Citations

Abstract

Cancer immunotherapy has recently undergone rapid advances and has become an integral part of the treatment armamentarium in various malignancies. However, tissue-based biomarker development in this arena has been slow, and valid biomarker identification to guide immunotherapeutic management is desperately needed. "Liquid" or blood-based biopsies potentially offer more convenient and efficient means to judge the immune milieu of individual patients and identify who will benefit most from immunotherapy. The following review highlights the current literature regarding the application of liquid biopsies to cancer immunotherapy.

Author List

Thompson JR, Menon SP

Authors

Smitha Menon MD Associate Professor in the Medicine department at Medical College of Wisconsin
Jonathan R. Thompson MD Assistant Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Biomarkers, Tumor
Humans
Immunotherapy
Liquid Biopsy
Neoplasms
jenkins-FCD Prod-486 e3098984f26de787f5ecab75090d0a28e7f4f7c0